Tetanus Vaccination Protocol for Adults

Primary Vaccination Series

The American College of Physicians recommends that adults with no prior tetanus vaccination or uncertain vaccination history should receive a complete 3-dose primary series: one dose of Tdap immediately, followed by Td at least 4 weeks later, and a third dose of Td 6-12 months after the second dose, providing nearly 100% protection against tetanus and establishing the foundation for long-term immunity 1
The Centers for Disease Control and Prevention (CDC) suggests that the first dose should be Tdap rather than Td alone, as this provides additional protection against pertussis, with a strength of evidence rated as high 2, 1

The Advisory Committee on Immunization Practices (ACIP) recommends that adults should receive booster doses every 10 years throughout life to maintain protection against tetanus and diphtheria, with a strength of evidence rated as high 3, 1
The American Academy of Family Physicians notes that one practical approach is to vaccinate at mid-decade ages (25, 35, 45 years) to ensure compliance, with a strength of evidence rated as moderate 1

The American College of Obstetricians and Gynecologists (ACOG) recommends that pregnant women should receive one dose of Tdap during EACH pregnancy at 27-36 weeks gestation, preferably during the earlier part of this period, regardless of prior Tdap history, providing passive antibody protection to the newborn during the vulnerable first months of life, with a strength of evidence rated as high 1, 2
The CDC recommends that all healthcare personnel with direct patient contact should receive a single dose of Tdap as soon as feasible if not previously received, with an interval as short as 2 years from the last Td dose acceptable, protecting both the healthcare worker and vulnerable patients from pertussis transmission, with a strength of evidence rated as high 2, 1

The American Academy of Emergency Medicine recommends that patients with ≥3 previous doses and last dose <10 years ago do not need a tetanus vaccine for clean, minor wounds, while those with ≥3 previous doses and last dose ≥10 years ago should receive tetanus toxoid (Tdap preferred if never received Tdap; otherwise Td), with a strength of evidence rated as high 1, 5
The CDC notes that contaminated wounds include puncture wounds, wounds contaminated with dirt/soil/feces/saliva, wounds with devitalized tissue, and injuries from metal objects in outdoor settings, requiring tetanus toxoid (Tdap preferred if never received Tdap; otherwise Td) and TIG 250 units IM at separate anatomic sites, with a strength of evidence rated as high 1, 5

The CDC recommends that the standard prophylactic dose of TIG is 250 units IM for both adults and children, with no weight-based dosing for prophylaxis, and human TIG is strongly preferred over equine antitoxin, with a strength of evidence rated as high 1

The CDC notes that absolute contraindications include history of anaphylaxis to vaccine components and encephalopathy within 7 days of previous pertussis-containing vaccine, while precautions include Guillain-Barré syndrome within 6 weeks of previous tetanus-containing vaccine and history of Arthus reaction following previous tetanus toxoid dose, with a strength of evidence rated as high 4, 1